Cipla Submits An Application With USFDA For A Generic Version Of Asthma Drug
![](https://healthwire.co/wp-content/uploads/2020/03/Cipla.jpg)
Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK’s Advair Diskus, which is used in the treatment…
Share